ARKK Holdings of RXRX
Recursion Pharmaceuticals
Recursion Pharmaceuticals operates as a biotechnology company that leverages machine learning and automation to discover new drugs and advance them through the drug development pipeline more efficiently. The company generates revenue primarily through partnerships and collaborations with other pharmaceutical firms, leveraging its proprietary technology and expertise to aid in drug discovery and development efforts.
Trades of RXRX in ARKK
The ten most recent trades of Recursion Pharmaceuticals in the ARKK ETF.View all trades
Date | Direction | Market Value | % of Position | % of ETF |
|---|---|---|---|---|
| Jan 10, 2025 | Buy | $1,832,989 | 1.42% | 0.03% |
| Jan 08, 2025 | Buy | $4,698,990 | 3.64% | 0.07% |
| Nov 20, 2024 | Buy | $1,963,614 | 1.85% | 0.03% |
| Nov 15, 2024 | Buy | $1,940,719 | 1.72% | 0.03% |
| Nov 04, 2024 | Buy | $683,371 | 0.62% | 0.01% |
| Nov 01, 2024 | Buy | $103,746 | 0.09% | 0.00% |
| Oct 30, 2024 | Buy | $2,234,223 | 1.96% | 0.04% |
| Oct 29, 2024 | Buy | $550,976 | 0.49% | 0.01% |
| Oct 08, 2024 | Buy | $636,129 | 0.60% | 0.01% |
| Sep 06, 2024 | Buy | $541,110 | 0.54% | 0.01% |